A. E. Eskazan, "Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.," Leukemia & lymphoma , vol.58, pp.2516-2517, 2017
Eskazan, A. E. 2017. Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.. Leukemia & lymphoma , vol.58 , 2516-2517.
Eskazan, A. E., (2017). Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.. Leukemia & lymphoma , vol.58, 2516-2517.
Eskazan, Ahmet. "Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.," Leukemia & lymphoma , vol.58, 2516-2517, 2017
Eskazan, Ahmet E. . "Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.." Leukemia & lymphoma , vol.58, pp.2516-2517, 2017
Eskazan, A. E. (2017) . "Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.." Leukemia & lymphoma , vol.58, pp.2516-2517.
@article{article, author={Ahmet Emre EŞKAZAN}, title={Additional chromosomal abnormalities at diagnosis or during tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.}, journal={Leukemia & lymphoma}, year=2017, pages={2516-2517} }